| Product Code: ETC7656981 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Neuromyelitis Optica Treatment Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Neuromyelitis Optica Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Neuromyelitis Optica Treatment Market - Industry Life Cycle |
3.4 Israel Neuromyelitis Optica Treatment Market - Porter's Five Forces |
3.5 Israel Neuromyelitis Optica Treatment Market Revenues & Volume Share, By Types, 2021 & 2031F |
3.6 Israel Neuromyelitis Optica Treatment Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 Israel Neuromyelitis Optica Treatment Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.8 Israel Neuromyelitis Optica Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Israel Neuromyelitis Optica Treatment Market Revenues & Volume Share, By End- Users, 2021 & 2031F |
4 Israel Neuromyelitis Optica Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neuromyelitis optica in Israel |
4.2.2 Growing awareness about the condition and available treatment options |
4.2.3 Technological advancements in the field of neurology and pharmaceuticals |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for new treatments |
4.3.2 High cost associated with neuromyelitis optica treatment |
4.3.3 Limited accessibility to specialized healthcare facilities in certain regions of Israel |
5 Israel Neuromyelitis Optica Treatment Market Trends |
6 Israel Neuromyelitis Optica Treatment Market, By Types |
6.1 Israel Neuromyelitis Optica Treatment Market, By Types |
6.1.1 Overview and Analysis |
6.1.2 Israel Neuromyelitis Optica Treatment Market Revenues & Volume, By Types, 2021- 2031F |
6.1.3 Israel Neuromyelitis Optica Treatment Market Revenues & Volume, By Neuromyelitis Optica Spectrum Disorder with Aquaporin-4 Antibodies, 2021- 2031F |
6.1.4 Israel Neuromyelitis Optica Treatment Market Revenues & Volume, By Neuromyelitis Optica Spectrum Disorder without Aquaporin-4 Antibodies, 2021- 2031F |
6.2 Israel Neuromyelitis Optica Treatment Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 Israel Neuromyelitis Optica Treatment Market Revenues & Volume, By Medication, 2021- 2031F |
6.2.3 Israel Neuromyelitis Optica Treatment Market Revenues & Volume, By Plasma Exchange Therapy, 2021- 2031F |
6.2.4 Israel Neuromyelitis Optica Treatment Market Revenues & Volume, By Immunoglobulin Therapy, 2021- 2031F |
6.3 Israel Neuromyelitis Optica Treatment Market, By Drugs |
6.3.1 Overview and Analysis |
6.3.2 Israel Neuromyelitis Optica Treatment Market Revenues & Volume, By C5 Protein Inhibitor, 2021- 2031F |
6.3.3 Israel Neuromyelitis Optica Treatment Market Revenues & Volume, By Oral Corticosteroid, 2021- 2031F |
6.3.4 Israel Neuromyelitis Optica Treatment Market Revenues & Volume, By Non-Steroid Immunosuppressive Drugs, 2021- 2031F |
6.3.5 Israel Neuromyelitis Optica Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Israel Neuromyelitis Optica Treatment Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Israel Neuromyelitis Optica Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Israel Neuromyelitis Optica Treatment Market Revenues & Volume, By Injectable, 2021- 2031F |
6.5 Israel Neuromyelitis Optica Treatment Market, By End- Users |
6.5.1 Overview and Analysis |
6.5.2 Israel Neuromyelitis Optica Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Israel Neuromyelitis Optica Treatment Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 Israel Neuromyelitis Optica Treatment Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.5 Israel Neuromyelitis Optica Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Neuromyelitis Optica Treatment Market Import-Export Trade Statistics |
7.1 Israel Neuromyelitis Optica Treatment Market Export to Major Countries |
7.2 Israel Neuromyelitis Optica Treatment Market Imports from Major Countries |
8 Israel Neuromyelitis Optica Treatment Market Key Performance Indicators |
8.1 Patient adherence rate to prescribed treatment regimens |
8.2 Number of clinical trials conducted for developing new treatments |
8.3 Rate of adoption of emerging therapies in the market |
9 Israel Neuromyelitis Optica Treatment Market - Opportunity Assessment |
9.1 Israel Neuromyelitis Optica Treatment Market Opportunity Assessment, By Types, 2021 & 2031F |
9.2 Israel Neuromyelitis Optica Treatment Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 Israel Neuromyelitis Optica Treatment Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.4 Israel Neuromyelitis Optica Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Israel Neuromyelitis Optica Treatment Market Opportunity Assessment, By End- Users, 2021 & 2031F |
10 Israel Neuromyelitis Optica Treatment Market - Competitive Landscape |
10.1 Israel Neuromyelitis Optica Treatment Market Revenue Share, By Companies, 2024 |
10.2 Israel Neuromyelitis Optica Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here